Pharmacovigilance: Regulatory and procedural guidance

  • Email
  • Help

The pharmacovigilance guidelines drawn up by the European Commission in accordance with Article 106 of Directive 2001/83/EC of the European Parliament and the Council are published as Volume 9A of The Rules Governing Medicinal Products in the EU.

Other guidelines not incorporated in Volume 9A as well as current and historical concept papers and draft guidelines under public consultation are contained in the table below.

See the full regulatory and procedural guidance index.

Table of contents


Guidance for marketing authorisation holders

Back to top

Document(s) Language Status First published Last updated Effective Date
Distribution requirements and address lists for periodic safety update reports (English only)   06/07/2001 20/04/2011  
Concept paper on compliance with pharmacovigilance regulatory obligations (English only) adopted 15/11/2001   01/01/2002
Template for EU risk management plan (EU-RMP) (English only) adopted 27/09/2006    

Guidance for competent authorities and the agency

Back to top

Document(s) Language Status First published Last updated Effective Date
Handling by the CPMP of safety concerns for pre- and post-authorisation applications submitted in accordance with the centralised procedure (English only) adopted 05/04/2004    

Product type - and population - specific guidance

Back to top

Pharmacovigilance practices

Back to top

Document(s) Language Status First published Last updated Effective Date
Draft guideline on detection and management of duplicate Individual Cases and Individual Case Safety Reports (ICSRs) (English only) draft: consultation closed 29/06/2010    
EudraLex – Volume 9A – Questions and answers on implementation - Version 5.4 (English only) adopted 29/03/2011    
Eudravigilance expert working group volume 9a implementation questions & answers - Version 3.2 (English only) adopted 21/10/2008    
Eudravigilance expert working group volume 9a implementation questions & answers - Version 1.2 (English only) adopted 28/02/2008    
Note for guidance: EudraVigilance Human – Processing of safety messages and individual case safety reports (ICSRs) (English only) adopted 03/08/2004 22/10/2010 07/02/2011
Implementation plan for the 'Note for guidance - EudraVigilance Human – Processing of safety messages and individual case safety reports (ICSRs) (EMEA/H/20665/04/Final Rev. 2) (English only) adopted 20/11/2009 22/10/2010  
Draft note for guidance: EudraVigilance Human version 7.1 - processing of safety messages and individual case safety reports (ICSRs) (English only) draft: consultation closed 31/01/2008    
Overview of comments received on draft note for guidance: EudraVigilance version 7.1 - Processing of safety messages and individual case safety reports (ICSRs) (Doc. Ref. EMEA/553390/2007) (English only)   20/11/2009    
Draft EudraVigilance access policy for medicines for human use (English only) draft 18/12/2008    
Guideline on the use of statistical signal detection methods in the Eudravigilance data analysis system (English only) adopted 26/06/2008   26/12/2008
Draft guideline on the use of statistical signal detection methods in the Eudravigilance data analysis system (English only) draft: consultation closed 15/11/2006    
Overview of comments received on draft guideline on the use of statistical signal detection methods in the Eudravigilance data analysis system (EMEA/106464/2006) (English only)   26/06/2008